Post job

Amneal Pharmaceuticals CEO and executives

Executive Summary. Based on our data team's research, Chirag K. Patel is the Amneal Pharmaceuticals's CEO. Amneal Pharmaceuticals has 6,500 employees, of which 25 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Amneal Pharmaceuticals executive team is 32% female and 68% male.
  • 49% of the management team is White.
  • 11% of Amneal Pharmaceuticals management is Hispanic or Latino.
  • 8% of the management team is Black or African American.
Work at Amneal Pharmaceuticals?
Share your experience

Rate Amneal Pharmaceuticals' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Chirag K. Patel

President, Co-Chief Executive Officer

Chirag K. Patel's LinkedIn

Mr. Patel’s lifelong drive and constant desire to discover what’s next has carried Amneal Pharmaceuticals from humble beginnings to an emerging global presence.

Patel is the recipient of several industry honors including the 2011 Ernst & Young National Entrepreneur of the Year Life Sciences Award® and supports various philanthropic and charitable causes both in the US and abroad. Patel and his wife, Priti Patel, established the Niswarth Children Foundation in 2013, with the goal of bringing fresh water, sanitation, sustenance, and education to one million underprivileged children.

Patel received his bachelor’s degree in commerce from H.A. College of Commerce, India, and his Bachelor of Science in business administration from New Jersey City University. He also received an honorary degree of doctor of humane letters from New Jersey City University in recognition of his efforts to serve others and help them transform their lives.

Patel serves on the boards of the Generic Pharmaceutical Association, the Art of Living Foundation, the New Jersey City University Foundation, and the Family Reach Foundation.

Chintu Patel

CEO

Anastasios Tasos Konidaris

Executive Vice President, Chief Financial Officer

Anastasios Tasos Konidaris's LinkedIn

Anastasios Konidaris is the Chief Financial Officer of Alcresta Therapeutics. He is also the Board Director at Kadmon Holdings and the Senior Advisor at Athyrium Capital Management.

Jeffrey P. George

Board Member

Paul M. Meister

Chairman

Shlomo Yanai

Board Member

Ted C. Nark

Board Member

Andrew S. Boyer

Executive Vice President, Chief Commercial Officer

Emily Peterson Alva

Board Member

Gautam Patel

Board Member

Do you work at Amneal Pharmaceuticals?

Does leadership effectively guide Amneal Pharmaceuticals toward its goals?

Amneal Pharmaceuticals jobs

Amneal Pharmaceuticals founders

Name & TitleBio
Chirag K. Patel

President, Co-Chief Executive Officer

Chirag K. Patel's LinkedIn

Mr. Patel’s lifelong drive and constant desire to discover what’s next has carried Amneal Pharmaceuticals from humble beginnings to an emerging global presence.

Patel is the recipient of several industry honors including the 2011 Ernst & Young National Entrepreneur of the Year Life Sciences Award® and supports various philanthropic and charitable causes both in the US and abroad. Patel and his wife, Priti Patel, established the Niswarth Children Foundation in 2013, with the goal of bringing fresh water, sanitation, sustenance, and education to one million underprivileged children.

Patel received his bachelor’s degree in commerce from H.A. College of Commerce, India, and his Bachelor of Science in business administration from New Jersey City University. He also received an honorary degree of doctor of humane letters from New Jersey City University in recognition of his efforts to serve others and help them transform their lives.

Patel serves on the boards of the Generic Pharmaceutical Association, the Art of Living Foundation, the New Jersey City University Foundation, and the Family Reach Foundation.

Chintu Patel

CEO

Amneal Pharmaceuticals board members

Name & TitleBio
Chirag K. Patel

President, Co-Chief Executive Officer

Chirag K. Patel's LinkedIn

Mr. Patel’s lifelong drive and constant desire to discover what’s next has carried Amneal Pharmaceuticals from humble beginnings to an emerging global presence.

Patel is the recipient of several industry honors including the 2011 Ernst & Young National Entrepreneur of the Year Life Sciences Award® and supports various philanthropic and charitable causes both in the US and abroad. Patel and his wife, Priti Patel, established the Niswarth Children Foundation in 2013, with the goal of bringing fresh water, sanitation, sustenance, and education to one million underprivileged children.

Patel received his bachelor’s degree in commerce from H.A. College of Commerce, India, and his Bachelor of Science in business administration from New Jersey City University. He also received an honorary degree of doctor of humane letters from New Jersey City University in recognition of his efforts to serve others and help them transform their lives.

Patel serves on the boards of the Generic Pharmaceutical Association, the Art of Living Foundation, the New Jersey City University Foundation, and the Family Reach Foundation.

Chintu Patel

CEO

Anastasios Tasos Konidaris

Executive Vice President, Chief Financial Officer

Anastasios Tasos Konidaris's LinkedIn

Anastasios Konidaris is the Chief Financial Officer of Alcresta Therapeutics. He is also the Board Director at Kadmon Holdings and the Senior Advisor at Athyrium Capital Management.

Jeffrey P. George

Board Member

Paul M. Meister

Chairman

Shlomo Yanai

Board Member

Ted C. Nark

Board Member

Emily Peterson Alva

Board Member

Gautam Patel

Board Member

J. Kevin Buchi

Board Member

Amneal Pharmaceuticals leadership demographics

Amneal Pharmaceuticals gender distribution in management team

  • The Amneal Pharmaceuticals executive team is 32% female and 68% male.
  • Amneal Pharmaceuticals is 36% female and 64% male company-wide.
Male
Male
68%
Company-wide: 64%
Female
Female
32%
Company-wide: 36%

Amneal Pharmaceuticals executives by race

Management Team:
  • The most common ethnicity among Amneal Pharmaceuticals executive officers is White.
  • 49% of the management team is White.
  • 28% of Amneal Pharmaceuticals's management is Asian.
  • 11% of the management team is Hispanic or Latino.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 36% of employees are White.
  • 35% of employees are Asian.
  • 13% of employees are Hispanic or Latino.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

Amneal Pharmaceuticals jobs nearby

Amneal Pharmaceuticals executives FAQs

Zippia gives an in-depth look into the details of Amneal Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Amneal Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Amneal Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Amneal Pharmaceuticals. The data presented on this page does not represent the view of Amneal Pharmaceuticals and its employees or that of Zippia.

Amneal Pharmaceuticals may also be known as or be related to Amneal Pharmaceuticals, Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals, Inc.